Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Myeloid-derived suppressor cells in cancer and cancer therapy.
Nat Rev Clin Oncol. 2024 Feb;21(2):147-164. doi: 10.1038/s41571-023-00846-y. Epub 2024 Jan 8.
Nat Rev Clin Oncol. 2024.
PMID: 38191922
Review.
Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs.
Lepper A, Bitsch R, Özbay Kurt FG, Arkhypov I, Lasser S, Utikal J, Umansky V.
Lepper A, et al. Among authors: ozbay kurt fg.
Oncoimmunology. 2023 Aug 13;12(1):2247303. doi: 10.1080/2162402X.2023.2247303. eCollection 2023.
Oncoimmunology. 2023.
PMID: 37593676
Free PMC article.
Item in Clipboard
Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target.
Ozbay Kurt FG, Lasser S, Arkhypov I, Utikal J, Umansky V.
Ozbay Kurt FG, et al.
J Clin Invest. 2023 Jul 3;133(13):e170762. doi: 10.1172/JCI170762.
J Clin Invest. 2023.
PMID: 37395271
Free PMC article.
Review.
Item in Clipboard
Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2.
Özbay Kurt FG, Lepper A, Gerhards C, Roemer M, Lasser S, Arkhypov I, Bitsch R, Bugert P, Altevogt P, Gouttefangeas C, Neumaier M, Utikal J, Umansky V.
Özbay Kurt FG, et al.
Front Immunol. 2022 Oct 12;13:1012526. doi: 10.3389/fimmu.2022.1012526. eCollection 2022.
Front Immunol. 2022.
PMID: 36311732
Free PMC article.
Item in Clipboard
HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling.
Arkhypov I, Özbay Kurt FG, Bitsch R, Novak D, Petrova V, Lasser S, Hielscher T, Groth C, Lepper A, Hu X, Li W, Utikal J, Altevogt P, Umansky V.
Arkhypov I, et al. Among authors: ozbay kurt fg.
J Immunother Cancer. 2022 Sep;10(9):e005551. doi: 10.1136/jitc-2022-005551.
J Immunother Cancer. 2022.
PMID: 36113897
Free PMC article.
Item in Clipboard
STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice.
Bitsch R, Kurzay A, Özbay Kurt F, De La Torre C, Lasser S, Lepper A, Siebenmorgen A, Müller V, Altevogt P, Utikal J, Umansky V.
Bitsch R, et al. Among authors: ozbay kurt f.
J Immunother Cancer. 2022 Mar;10(3):e004384. doi: 10.1136/jitc-2021-004384.
J Immunother Cancer. 2022.
PMID: 35301236
Free PMC article.
Item in Clipboard
Cite
Cite